Chronic obstructive pulmonary disease: towards pharmacogenetics. - Wikidata - wikimedia - TriplyDB

Chronic obstructive pulmonary disease: towards pharmacogenetics.

Chronic obstructive pulmonary disease: towards pharmacogenetics.

http://www.wikidata.org/entity/Q33600138

about

The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis Markers of Oxidative Stress in the Exhaled Breath Condensate of Workers Handling Nanocomposites

P2860

Q37894093-FA5F1B5D-21BB-4F40-94AF-481F5C148F16 Q38740756-21251BBB-7826-460A-ADAF-6E54D952D45A Q58586433-8C5D408F-27B0-4A1A-854B-FD84599E2BEE Q58789466-8BE09E57-FA53-4A70-9241-6D54A078000D

P2860

Chronic obstructive pulmonary disease: towards pharmacogenetics.

http://www.wikidata.org/entity/Q33600138

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Chronic obstructive pulmonary disease: towards pharmacogenetics.

@ast

Chronic obstructive pulmonary disease: towards pharmacogenetics.

@en

type

label

Chronic obstructive pulmonary disease: towards pharmacogenetics.

@ast

Chronic obstructive pulmonary disease: towards pharmacogenetics.

@en

prefLabel

Chronic obstructive pulmonary disease: towards pharmacogenetics.

@ast

Chronic obstructive pulmonary disease: towards pharmacogenetics.

@en

P1433

Q33600138-44AFFD40-400B-4296-B4AA-811F513CE08C

P1476

Q33600138-1B91DDAF-1FFA-475A-AC8E-FB2C7CC95252

P2093

Q33600138-3BAE88B0-0AB0-4214-A5E1-2A5CBE2D111A

Q33600138-85213CA9-0FC6-4401-9668-0825FB5C961E

Q33600138-9D4F1688-9FDB-4ED1-8E9B-9B36323AE0E0

P2860

Q33600138-01EAB1E0-8D3D-414C-81A8-B43E5194D2D7

Q33600138-04EB2EBE-8D6C-461C-8A72-E4A9AE6817AA

Q33600138-0506D6EA-969E-4EF0-9A9C-EAB5BA55FCA9

Q33600138-05988365-8408-451B-8004-6DB38CFC0D68

Q33600138-0829B943-F4BD-44BB-99DE-6C14656105BB

Q33600138-095D1E05-BCAF-40C0-83FB-6344651BEA5D

Q33600138-109F5987-4F22-4432-8B5A-D71E7499AC78

Q33600138-126E6924-F550-406E-8CE2-A2B63DFC9D3F

Q33600138-1386971A-82F2-4972-94DE-F5F084C896D1

Q33600138-13F5B499-E582-409F-9435-C596AE74ECF8

P2888

Q33600138-37439077-44B8-4C34-AD1A-E373EA771D12

P304

Q33600138-16F595D5-A108-4511-8B68-AC105688D01A

P31

Q33600138-7636D4C2-763C-4020-A7A1-2394B3C135A8

P356

Q33600138-1A9F217C-934A-4090-A0E7-D30C9C92DD32

P433

Q33600138-95EA97BB-2D44-4963-95ED-B9A3CB549ECD

P478

Q33600138-9BFA8B70-0F10-4FD5-B1D9-578A1794F0C8

P577

Q33600138-6C3DBE6D-E76C-4A93-8FDE-1D893E3B9034

P5875

Q33600138-395561F8-BDD5-41FA-98D4-677162BFD75A

P6179

Q33600138-280035FC-CF2E-4E90-9485-262BBED6F2CD

P698

Q33600138-01B04524-5D76-4C14-A1D9-A40D89C73DD6

P921

Q33600138-5BCBDCC7-8874-4E01-90B5-9C5963720800

P932

Q33600138-0D6EE057-170B-4E10-A503-9D2559F06202

P356

P1433

Genome Medicine

P1476

Chronic obstructive pulmonary disease: towards pharmacogenetics.

@en

P2093

Alice M Wood

http://www.w3.org/2001/XMLSchema#string

Robert A Stockley

http://www.w3.org/2001/XMLSchema#string

See Ling Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Global burden of COPD: systematic review and meta-analysis

The human hedgehog-interacting protein gene: structure and chromosome mapping to 4q31.21-->q31.3

Protease nexin. Properties and a modified purification procedure

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history

Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

Interpretative strategies for lung function tests

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

P2888

P304

112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/GM112

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40044487

http://www.w3.org/2001/XMLSchema#string

P6179

1000926538

http://www.w3.org/2001/XMLSchema#string

P698

19951401

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

2808747

http://www.w3.org/2001/XMLSchema#string